SARAH ROWE: Open Payments
NPI 1427549765 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,558 in 127 payments from 37 companies in 2025. Trend: 2023 $1,765 · 2024 $3,699 · 2025 $3,558
Food & beverage: $2,409Long term medical supply or device loan: $1,000Education: $149
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $1,185 |
| Janssen Biotech, Inc. | 11 | $285 |
| ABBVIE INC. | 7 | $185 |
| AstraZeneca Pharmaceuticals LP | 9 | $177 |
| Merck Sharp & Dohme LLC | 7 | $156 |
| E.R. Squibb & Sons, L.L.C. | 7 | $135 |
| BeOne Medicines USA, Inc. | 4 | $94 |
| GENZYME CORPORATION | 3 | $89 |
| PFIZER INC. | 7 | $85 |
| GlaxoSmithKline, LLC. | 4 | $79 |
Products named: KISQALI, DARZALEX, KEYTRUDA, OPDIVO, Lenvima, IMBRUVICA, IMFINZI, BRUKINSA.
Industry payments across FL — which companies pay providers there.
